Chapter 1 Inflammation, Angiogenesis, and Lymphangiogenesis

Methods in Enzymology

Volumn 445, Issue , 2008, Pages 1-25

  Halin, Cornelia ^a   Detmar, Michael ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BROXURIDINE; CD31 ANTIGEN; CELL SURFACE MARKER; KI 67 ANTIGEN; LYMPHATIC VASCULAR ENDOTHELIAL HYALURONAN RECEPTOR 1; MECA 32 ANTIGEN; PODOPLANIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PROX1; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN;

ANGIOGENESIS; BLOOD FLOW; BLOOD VESSEL; BLOOD VESSEL PERMEABILITY; CELL COUNT; CELL PROLIFERATION; CELL SUSPENSION; ENDOTHELIUM CELL; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LYMPH VESSEL; LYMPHANGIOGENESIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUANTITATIVE STUDY; REVIEW; STAINING;

ANIMALS; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; INFLAMMATION; LYMPHANGIOGENESIS; MICE; NEOVASCULARIZATION, PATHOLOGIC;

ANIMALIA;

EID: 56049090304     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(08)03001-2     Document Type: Review

References (79)

1. Alitalo K., Tammela T., and Petrova T.V. Lymphangiogenesis in development and human disease. Nature 438 (2005) 946-953
2. Angeli V., Ginhoux F., Llodra J., Quemeneur L., Frenette P.S., Skobe M., Jessberger R., Merad M., and Randolph G.J. B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 24 (2006) 203-215
3. Ballara S., Taylor P.C., Reusch P., Marme D., Feldmann M., Maini R.N., and Paleolog E.M. Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis. Arthritis Rheum. 44 (2001) 2055-2064
4. Baluk P., Fuxe J., Hashizume H., Romano T., Lashnits E., Butz S., Vestweber D., Corada M., Molendini C., Dejana E., and McDonald D.M. Functionally specialized junctions between endothelial cells of lymphatic vessels. J. Exp. Med. 204 (2007) 2349-2362
5. Baluk P., Tammela T., Ator E., Lyubynska N., Achen M.G., Hicklin D.J., Jeltsch M., Petrova T.V., Pytowski B., Stacker S.A., Yla-Herttuala S., Jackson D.G., Alitalo K., and McDonald D.M. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J. Clin. Invest. 115 (2005) 247-257
6. Banerji S., Ni J., Wang S.X., Clasper S., Su J., Tammi R., Jones M., and Jackson D.G. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J. Cell Biol. 144 (1999) 789-801
7. Baumhueter S., Singer M.S., Henzel W., Hemmerich S., Renz M., Rosen S.D., and Lasky L.A. Binding of L-selectin to the vascular sialomucin CD34. Science 262 (1993) 436-438
8. Baumhueter S., Dybdal N., Kyle C., and Lasky L.A. Global vascular expression of murine CD34, a sialomucin-like endothelial ligand for L-selectin. Blood 84 (1994) 2554-2565
9. Beasley N.J., Prevo R., Banerji S., Leek R.D., Moore J., van Trappen P., Cox G., Harris A.L., and Jackson D.G. Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res. 62 (2002) 1315-1320
10. Bhushan M., McLaughlin B., Weiss J.B., and Griffiths C.E. Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis. Br. J. Dermatol. 141 (1999) 1054-1060
11. Braverman I.M., and Keh-Yen A. Three-dimensional reconstruction of endothelial cell gaps in psoriatic vessels and their morphologic identity with gaps produced by the intradermal injection of histamine. J. Invest. Dermatol. 86 (1986) 577-581
12. Breier G., Breviario F., Caveda L., Berthier R., Schnurch H., Gotsch U., Vestweber D., Risau W., and Dejana E. Molecular cloning and expression of murine vascular endothelial-cadherin in early stage development of cardiovascular system. Blood 87 (1996) 630-641
13. Breiteneder-Geleff S., Soleiman A., Kowalski H., Horvat R., Amann G., Kriehuber E., Diem K., Weninger W., Tschachler E., Alitalo K., and Kerjaschki D. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: Podoplanin as a specific marker for lymphatic endothelium. Am. J. Pathol. 154 (1999) 385-394
14. Cao Y. Opinion: Emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis. Nat. Rev. Cancer 5 (2005) 735-743
15. Carvalho J.F., Blank M., and Shoenfeld Y. Vascular endothelial growth factor (VEGF) in autoimmune diseases. J. Clin. Immunol. 27 (2007) 246-256
16. Chidlow J.H., Shukla D., Grisham M.B., and Kevil C.G. Pathogenic angiogenesis in IBD and experimental colitis: New ideas and therapeutic avenues. Am. J. Physiol.Am. J. Physiol. Gastrointest. Liver Physiol. 293 (2007) G5-G18
17. Cohen T., Nahari D., Cerem L.W., Neufeld G., and Levi B.Z. Interleukin 6 induces the expression of vascular endothelial growth factor. J. Biol. Chem. 271 (1996) 736-741
18. Cueni L.N., and Detmar M. New insights into the molecular control of the lymphatic vascular system and its role in disease. J. Invest. Dermatol. 126 (2006) 2167-2177
19. Cursiefen C., Chen L., Borges L.P., Jackson D., Cao J., Radziejewski C., D'Amore P.A., Dana M.R., Wiegand S.J., and Streilein J.W. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J. Clin. Invest. 113 (2004) 1040-1050
20. Dadras S.S., Lange-Asschenfeldt B., Velasco P., Nguyen L., Vora A., Muzikansky A., Jahnke K., Hauschild A., Hirakawa S., Mihm M.C., and Detmar M. Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes. Mod. Pathol. 18 (2005) 1232-1242
21. Danese S., Sans M., Spencer D.M., Beck I., Donate F., Plunkett M.L., de la Motte C., Redline R., Shaw D.E., Levine A.D., Mazar A.P., and Fiocchi C. Angiogenesis blockade as a new therapeutic approach to experimental colitis. Gut 56 (2007) 855-862
22. De Bandt M., Ben Mahdi M.H., Ollivier V., Grossin M., Dupuis M., Gaudry M., Bohlen P., Lipson K.E., Rice A., Wu Y., Gougerot-Pocidalo M.A., and Pasquier C. Blockade of vascular endothelial growth factor receptor I (VEGF-RI), but not VEGF-RII, suppresses joint destruction in the K/BxN model of rheumatoid arthritis. J. Immunol. 171 (2003) 4853-4859
23. Detmar M., Brown L.F., Schon M.P., Elicker B.M., Velasco P., Richard L., Fukumura D., Monsky W., Claffey K.P., and Jain R.K. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J. Invest. Dermatol. 111 (1998) 1-6
24. Ebata N., Sawa Y., Nodasaka Y., Yamaoka Y., Yoshida S., and Totsuka Y. Immunoelectron microscopic study of PECAM-1 expression on lymphatic endothelium of the human tongue. Tissue Cell 33 (2001) 211-218
25. Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nat. Med. 9 (2003) 669-676
26. Folkman J. Tumor angiogenesis: Therapeutic implications. N. Engl. J. Med. 285 (1971) 1182-1186
27. Folkman J. Angiogenesis. Annu. Rev. Med. 57 (2006) 1-18
28. Groger M., Niederleithner H., Kerjaschki D., and Petzelbauer P. A previously unknown dermal blood vessel phenotype in skin inflammation. J. Invest. Dermatol. 127 (2007) 2893-2900
29. Grosios K., Wood J., Esser R., Raychaudhuri A., and Dawson J. Angiogenesis inhibition by the novel VEGF receptor tyrosine kinase inhibitor, PTK787/ZK222584, causes significant anti-arthritic effects in models of rheumatoid arthritis. Inflamm. Res. 53 (2004) 133-142
30. Halin C., and Detmar M. An unexpected connection: Lymph node lymphangiogenesis and dendritic cell migration. Immunity 24 (2006) 129-131
31. Halin C., Tobler N.E., Vigl B., Brown L.F., and Detmar M. VEGF-A produced by chronically inflamed tissue induces lymphangiogenesis in draining lymph nodes. Blood 110 (2007) 3158-3167
32. Hallmann R., Mayer D.N., Berg E.L., Broermann R., and Butcher E.C. Novel mouse endothelial cell surface marker is suppressed during differentiation of the blood-brain barrier. Dev. Dyn. 202 (1995) 325-332
33. Harrell M.I., Iritani B.M., and Ruddell A. Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. Am. J. Pathol. 170 (2007) 774-786
34. Hirakawa S., Hong Y.K., Harvey N., Schacht V., Matsuda K., Libermann T., and Detmar M. Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells. Am. J. Pathol. 162 (2003) 575-586
35. Hong Y.K., Shin J.W., and Detmar M. Development of the lymphatic vascular system: A mystery unravels. Dev. Dyn. 231 (2004) 462-473
36. Ilan N., and Madri J.A. PECAM-1: Old friend, new partners. Curr. Opin. Cell Biol. 15 (2003) 515-524
37. Jackson J.R., Seed M.P., Kircher C.H., Willoughby D.A., and Winkler J.D. The codependence of angiogenesis and chronic inflammation. FASEB J. 11 (1997) 457-465
38. Jeltsch M., Kaipainen A., Joukov V., Meng X., Lakso M., Rauvala H., Swartz M., Fukumura D., Jain R.K., and Alitalo K. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276 (1997) 1423-1425
39. Johnson L.A., Prevo R., Clasper S., and Jackson D.G. Inflammation-induced uptake and degradation of the lymphatic endothelial hyaluronan receptor LYVE-1. J. Biol. Chem. 282 (2007) 33671-33680
40. Jurjus A.R., Khoury N.N., and Reimund J.M. Animal models of inflammatory bowel disease. J. Pharmacol. Toxicol. Methods 50 (2004) 81-92
41. Kajiya K., Hirakawa S., and Detmar M. Vascular endothelial growth factor-A mediates ultraviolet B-induced impairment of lymphatic vessel function. Am. J. Pathol. 169 (2006) 1496-1503
42. Kanazawa S., Tsunoda T., Onuma E., Majima T., Kagiyama M., and Kikuchi K. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: A novel mechanism of chronic intestinal inflammation. Am. J. Gastroenterol. 96 (2001) 822-828
43. Kerjaschki D., Huttary N., Raab I., Regele H., Bojarski-Nagy K., Bartel G., Krober S.M., Greinix H., Rosenmaier A., Karlhofer F., Wick N., and Mazal P.R. Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. Nat. Med. 12 (2006) 230-234
44. Kerjaschki D., Regele H.M., Moosberger I., Nagy-Bojarski K., Watschinger B., Soleiman A., Birner P., Krieger S., Hovorka A., Silberhumer G., Laakkonen P., Petrova T., et al. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J. Am Soc. Nephrol. 15 (2004) 603-612
45. Kerr D.J. Targeting angiogenesis in cancer: Clinical development of bevacizumab. Nat. Clin. Pract. Oncol. 1 (2004) 39-43
46. Kim I., Moon S.O., Kim S.H., Kim H.J., Koh Y.S., and Koh G.Y. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J. Biol. Chem. 276 (2001) 7614-7620
47. Kitagaki H., Ono N., Hayakawa K., Kitazawa T., Watanabe K., and Shiohara T. Repeated elicitation of contact hypersensitivity induces a shift in cutaneous cytokine milieu from a T helper cell type 1 to a T helper cell type 2 profile. J. Immunol. 159 (1997) 2484-2491
48. Koch A.E., Polverini P.J., Kunkel S.L., Harlow L.A., DiPietro L.A., Elner V.M., Elner S.G., and Strieter R.M. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258 (1992) 1798-1801
49. Kuhn R., Lohler J., Rennick D., Rajewsky K., and Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75 (1993) 263-274
50. Kunstfeld R., Hirakawa S., Hong Y.K., Schacht V., Lange-Asschenfeldt B., Velasco P., Lin C., Fiebiger E., Wei X., Wu Y., Hicklin D., Bohlen P., and Detmar M. Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia. Blood 104 (2004) 1048-1057
51. Lange-Asschenfeldt B., Weninger W., Velasco P., Kyriakides T.R., von Andrian U.H., Bornstein P., and Detmar M. Increased and prolonged inflammation and angiogenesis in delayed-type hypersensitivity reactions elicited in the skin of thrombospondin-2-deficient mice. Blood 99 (2002) 538-545
52. Lee T.H., Avraham H., Lee S.H., and Avraham S. Vascular endothelial growth factor modulates neutrophil transendothelial migration via up-regulation of interleukin-8 in human brain microvascular endothelial cells. J. Biol. Chem. 277 (2002) 10445-10451
53. Leibovich S.J., Polverini P.J., Shepard H.M., Wiseman D.M., Shively V., and Nuseir N. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature 329 (1987) 630-632
54. Magnusson P., Rolny C., Jakobsson L., Wikner C., Wu Y., Hicklin D.J., and Claesson-Welsh L. Deregulation of Flk-1/vascular endothelial growth factor receptor-2 in fibroblast growth factor receptor-1-deficient vascular stem cell development. J. Cell Sci. 117 (2004) 1513-1523
55. Makinen T., Veikkola T., Mustjoki S., Karpanen T., Catimel B., Nice E.C., Wise L., Mercer A., Kowalski H., Kerjaschki D., Stacker S.A., Achen M.G., and Alitalo K. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J. 20 (2001) 4762-4773
56. Mor F., Quintana F.J., and Cohen I.R. Angiogenesis-inflammation cross-talk: vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization. J. Immunol. 172 (2004) 4618-4623
57. Morabito A., De Maio E., Di Maio M., Normanno N., and Perrone F. Tyrosine kinase inhibitors of vascular endothelial growth factor receptors in clinical trials: Current status and future directions. Oncologist 11 (2006) 753-764
58. Nagy J.A., Vasile E., Feng D., Sundberg C., Brown L.F., Detmar M.J., Lawitts J.A., Benjamin L., Tan X., Manseau E.J., Dvorak A.M., and Dvorak H.F. Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J. Exp. Med. 196 (2002) 1497-1506
59. Oliver G., Sosa-Pineda B., Geisendorf S., Spana E.P., Doe C.Q., and Gruss P. Prox 1, a prospero-related homeobox gene expressed during mouse development. Mech. Dev. 44 (1993) 3-16
60. Padera T.P., Stoll B.R., So P.T., and Jain R.K. Conventional and high-speed intravital multiphoton laser scanning microscopy of microvasculature, lymphatics, and leukocyte-endothelial interactions. Mol. Imaging 1 (2002) 9-15
61. Paleolog E.M. Angiogenesis in rheumatoid arthritis. Arthritis Res. 4 Suppl 3 (2002) S81-S90
62. Park C.C., Morel J.C., Amin M.A., Connors M.A., Harlow L.A., and Koch A.E. Evidence of IL-18 as a novel angiogenic mediator. J. Immunol. 167 (2001) 1644-1653
63. Pertovaara L., Kaipainen A., Mustonen T., Orpana A., Ferrara N., Saksela O., and Alitalo K. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J. Biol. Chem. 269 (1994) 6271-6274
64. Pober J.S., and Sessa W.C. Evolving functions of endothelial cells in inflammation. Nat. Rev. Immunol. 7 (2007) 803-815
65. Raychaudhuri S.P., Dutt S., Raychaudhuri S.K., Sanyal M., and Farber E.M. Severe combined immunodeficiency mouse-human skin chimeras: A unique animal model for the study of psoriasis and cutaneous inflammation. Br. J. Dermatol. 144 (2001) 931-939
66. Ristimaki A., Narko K., Enholm B., Joukov V., and Alitalo K. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J. Biol. Chem. 273 (1998) 8413-8418
67. Saharinen P., Tammela T., Karkkainen M.J., and Alitalo K. Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation. Trends Immunol. 25 (2004) 387-395
68. Sawano A., Iwai S., Sakurai Y., Ito M., Shitara K., Nakahata T., and Shibuya M. Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans. Blood 97 (2001) 785-791
69. Schacht V., Ramirez M.I., Hong Y.K., Hirakawa S., Feng D., Harvey N., Williams M., Dvorak A.M., Dvorak H.F., Oliver G., and Detmar M. T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J. 22 (2003) 3546-3556
70. Skobe M., and Detmar M. Structure, function, and molecular control of the skin lymphatic system. J. Invest. Dermatol. Symp. Proc. 5 (2000) 14-19
71. Skobe M., Hamberg L.M., Hawighorst T., Schirner M., Wolf G.L., Alitalo K., and Detmar M. Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am. J. Pathol. 159 (2001) 893-903
72. Sugiura T., Oka S., Gokoh M., Kishimoto S., and Waku K. New perspectives in the studies on endocannabinoid and cannabis: 2-arachidonoylglycerol as a possible novel mediator of inflammation. J. Pharmacol. Sci. 96 (2004) 367-375
73. Szekanecz Z., and Koch A.E. Mechanisms of disease: Angiogenesis in inflammatory diseases. Nat. Clin. Pract. Rheumatol. 3 (2007) 635-643
74. Thurston G., Murphy T.J., Baluk P., Lindsey J.R., and McDonald D.M. Angiogenesis in mice with chronic airway inflammation: Strain-dependent differences. Am. J. Pathol. 153 (1998) 1099-1112
75. Wigle J.T., and Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell 98 (1999) 769-778
76. Wirtz S., Neufert C., Weigmann B., and Neurath M.F. Chemically induced mouse models of intestinal inflammation. Nat. Protoc. 2 (2007) 541-546
77. Xia Y.P., Li B., Hylton D., Detmar M., Yancopoulos G.D., and Rudge J.S. Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood 102 (2003) 161-168
78. Yin G., Liu W., An P., Li P., Ding I., Planelles V., Schwarz E.M., and Min W. Endostatin gene transfer inhibits joint angiogenesis and pannus formation in inflammatory arthritis. Mol. Ther. 5 (2002) 547-554
79. Zenz R., Eferl R., Kenner L., Florin L., Hummerich L., Mehic D., Scheuch H., Angel P., Tschachler E., and Wagner E.F. Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 437 (2005) 369-375